This website is for Israeli Healthcare Professionals only

AbbVie's Future Molecules in IBD

 

 

Podcasts From The 17th Congress of ECCO Viewing Event

 

Listen To Leading Experts Presentations

Watch Dr. Matti Waterman, Prof. Ariella Bar-Gil ShitritDr. Irit Avni Biron speak about new modes of action in IBD & AbbVie’s future molecules.

{{currentVideo.name}}
{{currentVideo.name}}

{{currentVideo.description}}


{{currentVideo.long_description}}


  

{{currentVideo.name}}
{{currentVideo.name}}

{{currentVideo.description}}


{{currentVideo.long_description}}


 

Lectures From The 16th Congress of ECCO Viewing Event

 

View Leading Experts Presentations

Watch Dr. Matti Waterman, Prof. Ariella Bar-Gil ShitritDr. Irit Avni Biron speak about new modes of action in IBD & AbbVie’s future molecules.

Duration 22:08

New molecules for IBD
Dr. Irit Avni Biron

Duration 22:57

AbbVie's future molecules in IBD 
Prof. Ariella Bar-Gil Shitrit

Duration 22:24

New MOA & AbbVie’s pipeline in IBD
Dr. Matti Waterman

AbbVie’s Symposia Agenda

For ECCO registered attendees, the induction results of Risankizumab in CD and Upadacitinib in UC are available in the scientific program (oral presentations), and as part of Abbvie's symposia.

To view AbbVie’s symposia agenda click here


 

RISN-IL-00007-MC